RDY
Dr. Reddy’s Laboratories Ltd
12.30$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,154.1% | 6.6% | 0.2% | 11.1% | 11.6% | 7.9% | 25.9% | 17.1% | 17.7% | 12.5% | 20.2% | -1.1% | 12.3% | |
| 455.3% | 5.2% | 0.1% | 5.0% | 5.0% | 5.6% | 5.4% | 5.6% | 5.7% | 6.0% | 7.4% | 6.6% | 6.4% | |
| 12.4% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | 0.1% | 0.1% | 0.1% | |
| -393.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 313.5% | -16.4% | 0.0% | -17.1% | -9.7% | -11.5% | 0.7% | -9.6% | -2.9% | -9.3% | 10.2% | -14.8% | -4.5% | |
| 473.3% | 7.0% | 0.1% | 8.4% | 9.9% | 10.6% | 13.2% | 11.9% | 11.5% | 8.4% | 6.1% | 4.6% | 7.8% | |
| -1,532.4% | – | -0.2% | -26.4% | -23.8% | -6.5% | -15.6% | -22.5% | -10.8% | -11.8% | -37.0% | 4.7% | -13.3% | |
| 798.8% | 0.0% | 0.0% | 0.0% | 8.3% | 0.0% | 7.8% | 0.0% | 7.6% | 0.1% | 0.1% | 0.0% | 2.0% | |
| 91.9% | – | 1.1% | – | 0.2% | – | -1.6% | – | 0.3% | – | – | – | – | |
| -70.5% | – | – | – | 20.7% | 1.8% | -6.0% | -0.3% | 2.7% | 9.9% | 10.7% | -7.2% | 4.0% | |
| -845.5% | 7.3% | 0.0% | 12.4% | 20.1% | 0.7% | -8.7% | -1.4% | -6.0% | 8.9% | 11.4% | -8.8% | 1.2% | |
| 757.9% | -8.3% | 0.0% | -2.9% | 7.9% | 2.1% | 1.8% | -6.5% | 1.0% | 10.0% | -5.5% | -5.1% | 0.4% | |
| 1,680.7% | -0.4% | 0.1% | 2.7% | 1.8% | -2.6% | 12.6% | 5.2% | 6.2% | 4.1% | 14.1% | -5.7% | 4.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.